C & A Modas S.A. (CEAB3R)

Sick post!!!! Good BYE Gailm...

I AM THINKING .04 BY END OF AUGUST IMO.WE WILL SEE IF AM RIGHT.

YW....there's a lot of other info on that chart.... BV - Book Value, EPS, PE, 5 Days of RSI.......MACD and 50/200 MA info

In the main program you can also push buttons for news, filings, etc.........and there's also a Scanner to find winners

Z

Total shareholders is sub 300 all the same. Lies a lie dog. I only have like probably 30 others.

#DDAmanda Chart on $TSLA.

Check our 4th of July Special! https://DDAmanda.com

https://DDAmanda.com/Charts/DDAmandaTSLA.jpg

#DDAmanda

Z

#DDAmanda Chart on $TSLA.

Check our 4th of July Special! https://DDAmanda.com

https://DDAmanda.com/Charts/DDAmandaTSLA.jpg

#DDAmanda

Z

Excellent point Peach, ✅ ”unlike their American counterparts”

So the US Cattle farmers are Not Fooled and the India Cattle farmers are Not Fooled.

SURAEC isn't fooled either,

Using bagasse in beef cattle diets as a hay substitute COULD BE beneficial in ti

ONLY a breakdown in the DEAL seems a likely candidate for a CRASH. but it has to be decisive. TACO is not likely to bite unless his humiliation gest the better of him. I EXPECTED him to be FORCED to fight instead of signing such an embarrassing defeat deal. I was WRONG. But IRAN is pushing it for

#DDAmanda Chart on $TSLA.

Check our 4th of July Special! https://DDAmanda.com

https://DDAmanda.com/Charts/DDAmandaTSLA.jpg

#DDAmanda

Z

FDA sanity returning.

Thanks Kiwi👍

GL...

Interesting read -
Wall Street Peer ComparisonsTo gauge where a successful medical device company in this niche can trade, retail investors often look at peer companies targeting localized cancer therapies:Company / Asset ClassClinical StageTypical

Market Cap Visualized Equiv

Thanks for sharing the details on the Duke/Schaal ELP + I-131 work.

The 2022 Nature Biomedical Engineering paper showed impressive preclinical results in mouse pancreatic cancer models (strong tumor regression, especially combined with nanoparticle paclitaxel). That’s meaningful data

97,11,5,71

I suggest people read your informative IFUS post again so that it makes sense with my comments

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740678

YOU stated

If I were the interim CEO of IFUS right now, what would I do? Let's just set

UNCY's UniSource hub .
I suggest you all read up on this B2B plan UNCY is starting to make it really easy for dialysis centers to prescribe , store and bill for OLC .
Its designed to over come a lot of the hurdles , drug co's face launching new drugs into a field dominated by Freseniu

Exactly eagle8.
I think once we use DCVax-L plus Poly-ICLC, DCVax-D+ and aDC1 treatments in other cancer types we will see tremendous price movement.

Well, I don’t have my shares yet so they are worth nothing. More optimistic now that I might actually get them. 

Let the piggy bank eat .


The excitement builds

You  as well aqua

Hell yeah kj thanks for all your DD much appreciated let's go FITY

In over 25 years

It's quite a feature, isn't it?

What seems to always be missing here is that RadioGel was NOT the first thermogel with a radionuclide. It's even in their "prior art" section on their original patent from 1998!

And there have been many oth

starric, as usual, thanks for your posts.

The ultimate goal for NWBO is, of course, DCvax-Direct.
With the Kalinski method, aDCs, we won't need many adjuvants anymore.
Then only the companies with the most necessary adjuvants will benefit.
And there aren't that ma